Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Psoriasis”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07158268
What this trial is testing

HSK47388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Haisco Pharmaceutical Group Co., Ltd. 220
Large-scale testing (Phase 3)Study completedNCT04036435
What this trial is testing

Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 1,466
Large-scale testing (Phase 3)UnknownNCT06299982
What this trial is testing

An Phase III Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With PsO

Who this might be right for
Plaque Psoriasis Patients
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 750
Large-scale testing (Phase 3)Study completedNCT01206660
What this trial is testing

Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries, Inc. 120
Testing effectiveness (Phase 2)Study completedNCT00725348
What this trial is testing

An Open-Label, Multi-Center Trial in the Treatment of Subjects With Moderate to Severe Plaque Type Psoriasis

Who this might be right for
Psoriasis
Stiefel, a GSK Company 19
Post-approval studies (Phase 4)Study completedNCT06329258
What this trial is testing

Combination of Sotyktu and Enstilar for Plaque Psoriasis

Who this might be right for
Psoriasis
Psoriasis Treatment Center of Central New Jersey 30
Large-scale testing (Phase 3)Study completedNCT02409667
What this trial is testing

Plaque Psoriasis Efficacy and Safety With Secukinumab

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 16,487
Testing effectiveness (Phase 2)Study completedNCT02888236
What this trial is testing

LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 36
Not applicableStudy completedNCT02155192
What this trial is testing

An Exploratory Genetic Study in Participants With Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 712
Large-scale testing (Phase 3)Study completedNCT03219437
What this trial is testing

A Study Comparing the Safety and Efficacy of Risankizumab to Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 104
Post-approval studies (Phase 4)Ended earlyNCT00608777
What this trial is testing

Effect of Topical Calcipotriene/Betamethasone (Taclonex) in Managing Localized Breakthrough in Moderate to Severe Plaque Psoriasis in Patients Receiving Efalizumab (Raptiva)

Who this might be right for
Plaque Psoriasis
Derm Research, PLLC 6
Testing effectiveness (Phase 2)Study completedNCT01384630
What this trial is testing

Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 8
Testing effectiveness (Phase 2)Study completedNCT03000075
What this trial is testing

BI 655066 (Risankizumab) Compared to Placebo in Japanese Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 182
Large-scale testing (Phase 3)Study completedNCT07712731
What this trial is testing

HPP737 in Adult Patients With Plaque Psoriasis

Who this might be right for
Psoriasis
Newsoara Biopharma Co., Ltd. 607
Testing effectiveness (Phase 2)Study completedNCT04173637
What this trial is testing

Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Akeso 330
Testing effectiveness (Phase 2)UnknownNCT06058546
What this trial is testing

Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Tasly Pharmaceutical Group Co., Ltd 180
Large-scale testing (Phase 3)Study completedNCT01365455
What this trial is testing

Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 738
Large-scale testing (Phase 3)Study completedNCT06973291
What this trial is testing

A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Takeda 606
Testing effectiveness (Phase 2)Study completedNCT00333411
What this trial is testing

Double-blind, Randomised, Placebo-controlled Trial Investigating BIRT 2584 XX in Patients With Moderate/Severe Psoriasis

Who this might be right for
Psoriasis
Boehringer Ingelheim 360
Testing effectiveness (Phase 2)Study completedNCT02129777
What this trial is testing

Efficacy and Safety of Namilumab (MT203) for Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Takeda 122
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation